Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M. Sperger, Joshua M. Lang, Felix Y. Feng et al.|Journal of Clinical Oncology|2021Cited by 62
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G. Zhao, Joshua M. Lang, Jamie M. Sperger et al.|Journal of Clinical Investigation|2022Cited by 33
SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samplesTamara S. Rodems, Joshua M. Lang, Duane S. Juang et al.|Clinical Epigenetics|2022Cited by 7
Abstract 7023: Application of exclusive liquid repellency for low input CUT&Tag histone analyses in prostate cancer spheroidsZachary J. Kauffman, Joshua M. Lang, Kevin Koesser et al.|Cancer Research|2024Cited by 0
Abstract 1955: Simultaneous longitudinal assessment of PIK3CA genomic mutations and PI3K pathway activity in circulating tumor cells in metastatic breast cancerMarina N. Sharifi, Joshua M. Lang, Kyle T. Helzer et al.|Cancer Research|2022Cited by 0